The Observable Universe of SpaceX (SPCX)

The Observable Universe of SpaceX (SPCX)

A series on the largest IPO in history. The goal is simple: map what we can actually verify, before the sales narrative fills in the rest of the sky.

Astronomers use a careful phrase. The observable universe. It means the part of the cosmos we can actually see and measure. Light from anything farther away has not had time to reach us yet. Beyond that edge, there may be infinitely more. But we cannot observe it. We can only tell stories about it.

SpaceX has an observable universe too. It is made of filings, share counts, dollar figures, ownership records, and lockup terms. These are facts. We can check them.

It also has an unobservable one. Mars. Orbital data centers. A galactic civilization. A trillion dollars of future artificial intelligence revenue. These are the sales narrative. They may even come true. But right now they are stories, not facts.

This series stays in the observable part. I will map what can be verified. Then you can decide for yourself how much of the story to buy.

Article 1. Stop Thinking of This as a Rocket Company

I have watched many IPOs cross the tape over six decades. I cannot recall one where the public's picture of the business was this far behind the facts.

SpaceX lists on the Nasdaq on June 12. The ticker is SPCX. Most readers still picture a reusable-rocket pioneer. That picture is out of date. The gap between the picture and the reality is the most valuable thing you can understand before this prices.

Three facts have hardened from rumor into reality. Start with these.

Pillar one: the price is fixed.

On June 3, SpaceX set a fixed price of $135.00 per Class A share.
It is selling roughly 555.6 million shares to raise about $75 billion.
Underwriters hold an option on another 83.33 million shares.
That marks the whole company at about $1.77 trillion.
On arrival it would be the seventh largest company in the United States, above Tesla.
By the size of the raise, it is the largest IPO ever. It edges out Saudi Aramco.

Here is that scale in plain terms. At roughly $1.8 trillion, this one company is about half the total value of the entire S&P MidCap 400. On the figures at the end of January, it was larger than the whole S&P SmallCap 600. One founder-controlled company, set against four hundred or six hundred others. Keep that in mind. The slice being sold to you is tiny.

Pillar two: this is no longer a launch company.

In February, SpaceX absorbed xAI in an all-stock deal. That valued the combined company near $1.25 trillion.
The prospectus now calls the business an artificial intelligence services and infrastructure company.
The combined company lost about $4.94 billion in 2025.
The AI unit alone burned about $7.72 billion in the first quarter of 2026.

So the buyer at $135 is not buying a rocket maker throwing off profits. The buyer is purchasing a conglomerate that loses money at scale.

Pillar three: the money is largely already spent.

More than three quarters of the raise is committed before it arrives.
It goes to repay debt held by Valor Equity Partners, X Corp, and xAI investors, plus a spectrum payment to EchoStar.
Total debt sits near $29.1 billion.
That includes a $20 billion bridge loan due within about six months of the IPO closing.
After the pledged uses, less than $18 billion is left for the new buildout.

The marketing says fresh capital for Mars and orbital compute. The footnotes say refinancing.

The skeptic's ledger

I do not raise the bear case to talk anyone out of anything. I raise it because for the readers I write for, the bear case is the spine of disciplined thinking. Here it is, item by item.

Valuation. Morningstar puts fair value near $780 billion. That is about 48 percent below the offering mark. The ask works out to roughly 67 times sales. That is about three times Nvidia's multiple.
Profitability. You are buying losses today against a promise of scale tomorrow.
Balance sheet. That $20 billion bridge loan comes due within half a year.
Governance. Musk controls about 82 percent of the vote on a 42 percent stake. Only Musk can remove Musk.
Dilution. The filing warns, in plain language, that it may issue significant equity in future deals.
Execution. The company's own risk factors admit it cannot yet source enough chips for orbital AI. They say its flagship chip project may fail.
Price support. A thin float, a syndicate of more than twenty banks, and a fast track into the Nasdaq 100 within about fifteen trading days create forced buying. That can hold the price up no matter what the fundamentals say, at least for a while.

Now the hook for the whole series, stated plainly. This is an artificial intelligence conglomerate burning cash. It is offered at a price that requires near perfection. You get no vote. The only check on management is management itself. Everything that follows shows you, piece by piece, how that came to be true, and what it means for your capital.

Article 2. What the Independent Analysts Actually Say

People keep treating the offering price as the market's verdict on value. It is not.

The price is simply where a group of more than twenty banks thinks it can place a small float. Those banks are underwriters, not analysts. They are paid to sell the deal. They will not publish a fair-value estimate before the listing. Their later research will be conflicted by their role.

So the only honest valuation work comes from independent houses. Several have published. Here is what they found. Almost all of it lands below the offering price.

Morningstar's $780 billion, taken apart

The headline number is not a guess. It is a discounted cash flow from a named analyst, Nicolas Owens. The way he builds it is the useful part.

He values the launch business and Starlink together at about $611 billion.
This is the part he trusts. Starlink is the one clearly profitable line. It made about $4.4 billion in operating income in 2025.
The launch business is a near-monopoly. It lifted about 83 percent of all mass sent to orbit in 2025 and cut cost per kilogram by more than 95 percent.
To the entire AI side, xAI included, he assigns only about $170 billion. He weights that across many possible outcomes, not as a confident forecast.
He calls xAI a material threat of value destruction. He says its moat is at best narrow. He notes that Grok trails the leaders and must fight OpenAI, Anthropic, Amazon, Google, and Microsoft.

The two pieces blend to about $780 billion. His advice is blunt. Do not buy at the IPO. He expects better prices later, with a greater margin of safety, once the float grows and the hype fades. Even Owens, the toughest bear, admits the thin float and index inclusion could push the price up short term. The bear and the bull agree on the mechanics. They disagree only on whether the mechanics have anything to do with value.

The rest of the field

Aswath Damodaran, the New York University professor known as the dean of valuation, did his own work in late April.

Base case: about $1.2 trillion.
His simulation gave a median near $1.28 trillion, across a range from $660 billion to $2.8 trillion.
He placed the offering price at the top of that range. He said he would be reluctant to buy there.
He is no hater. He owns Tesla. He calls SpaceX Musk's most impressive contribution.
His best line for readers: you get the Musk package, the good and the bad together. And companies are priced, not valued, at an IPO.

PitchBook, through analyst Franco Granda, ran its own sum-of-the-parts study.

Fair-value range: $1.1 trillion to $1.7 trillion. The offering target sits inside that band.
It referred to the valuation as rich but not irrational.
It said the number only becomes defensible over a five-to-seven-year horizon.
Quiet irony worth noting: PitchBook is Morningstar's own private-markets arm. It landed far more generous than the Morningstar equity desk. Two teams inside one company disagree. That tells you how wide the honest uncertainty is.

New Constructs, run by David Trainer, sits at the bearish extreme.

Its advice is flat: avoid the IPO.
Its argument: the raise funds debt and an AI race, not profit.
It expects tough competition and pricing pressure from Amazon, Google, and Microsoft.

Oppenheimer is the clearest bull.

It treats SpaceX as a communications platform, not a rocket maker.
It argues Starlink could disrupt the roughly $1.6 trillion United States telecom market.
It did not attach one tidy figure, but its posture is the case for the offering price.

Jack Ciesielski, an accounting specialist, is a conditional bull. He called the target a moonshot. It works, he said, only if SpaceX keeps both a fast-growing market and real monopoly power.

For market-implied anchors: private secondary trades on Forge Global valued the company near $1.53 trillion. The February xAI merger set an internal mark near $1.25 trillion. The target itself was walked down from a rumored $2 trillion before pricing near $1.77 trillion.

The spectrum, in one view

Source	Independent of the deal	Fair value or stance	One-line read
New Constructs (Trainer)	Yes	Avoid the IPO	Funds debt and an AI race, not profit.
Morningstar (Owens)	Yes	About $780 billion	$611B core plus $170B AI. Overvalued; wait.
Damodaran (NYU)	Yes	About $1.2 trillion base	Reluctant to buy at the ask.
PitchBook (Granda)	Yes	$1.1 to $1.7 trillion	Rich but not irrational; a five-year story.
Oppenheimer	Yes	Bullish, no figure	Platform, not rocket maker.
Ciesielski	Yes	"Moonshot"	Needs growth plus monopoly power.
Forge Global secondary	Market-implied	About $1.53 trillion	What private buyers paid.
The offering	No, underwriters	About $1.77 trillion	Down from a rumored $2 trillion.

Three things to take away

The offering is priced at the top of, or above, every independent estimate except the bullish platform story.
The whole fight is about the AI side, not the rockets. Every serious analyst trusts Starlink and the launch monopoly. The gap between $780 billion and $1.8 trillion is one question: is xAI and orbital compute worth a trillion dollars today, or close to nothing? You are not betting on rockets. You are paying a trillion-dollar premium for an unproven AI bet wrapped around a profitable satellite company.
The independent field is nearly unanimous on one point. The better entry comes after the IPO. That is not timing advice, and I will not dress it up as such. It is simply what the disinterested analysts are saying, in chorus. When the only people urging you to pay this price are the people paid to sell it, that is information in itself.

Article 3. Who Owns the Trillion Dollars

Readers keep asking the same thing. If SpaceX is worth $1.77 trillion, and it is only raising $75 billion, who owns the other $1.7 trillion? And what did they pay?

It is the right question. The answer corrects a common mistake.

The other $1.7 trillion is not a separate pile of shares. It is a mark. It is the value of the existing equity once you price the whole company at the new number.

The owners are insiders and private investors. Musk is dominant.
The $75 billion float is only about 4.2 percent of the company.
That value is a mark, not cash, and not a realized gain.
Pre-IPO holders cannot all sell into a 4 percent float. Lockups bind the insiders.
The small float is part of the design. A thin float, heavy bank support, and strong AI demand are how a money-losing company still expects its shares to hold or rise on day one.

On cost basis, there is no single answer. Anyone who gives you one is guessing.

SpaceX raised money across more than thirty rounds over two decades.
Valuations climbed from about $12 billion in 2015, to $137 billion in early 2023, to $1.25 trillion at the xAI merger.
Musk's earliest shares cost almost nothing in relative terms.
A fund that bought in 2023, or an employee who sold at about $420 a share late in 2025, has a completely different basis.
The xAI merger adds another layer. Former xAI holders swapped into SpaceX stock and carried their old basis with them.

So here is the line I would stake my name on. Cost basis is holder-specific and round-specific. In most cases it is simply not public. You cannot infer it from the IPO price.

And the reframing I want you to keep: the IPO does not create $1.7 trillion of new wealth. It converts an illiquid private mark into a liquid public one, for a sliver of the shares. The wealth was already on paper in February. The listing just makes it visible, partly liquid, and, through index funds, something the rest of us will own whether we want to or not. That last point is Article 5.

Article 4. Votes Without Dollars

If you read only one article in this series, read this one. The structure here governs how the company will be run for the rest of Musk's life.

Two questions sound the same. They are not.

How much of the company do you own? That is economics.
How much say do you have in running it? That is control.

SpaceX is going public in a way that splits the two apart.

The share structure has three classes.

Class A, sold to the public, carries one vote each.
Class B, held by Musk, carries ten votes each.
A third class, non-voting, with up to ten billion authorized, exists for one reason: to let the company issue stock in future deals without weakening Musk's control.

All three classes have nearly the same economic rights. They differ only in votes.

Now the arithmetic.

Musk holds about 42 percent of the equity.
He controls about 82.4 percent of the vote.
That control comes mostly from his Class B shares, on the order of 5.2 billion of them.
Older estimates run from about 79 percent to roughly 85 percent. I use the 82.4 percent from the latest filing and treat the spread as a lesson in how these numbers shift.

In plain language: Musk controls the company while owning well under half of it.

The filing says he can elect the entire board.
Removing him as chief executive or chairman needs a majority of Class B shares. He holds them.
The shorthand is exact. Only Musk can fire Musk.
The company is a controlled company. That exempts it from some Nasdaq governance rules, such as a majority-independent board.
Disputes go to mandatory arbitration. No class actions. No jury trials.

A pension fund buying this stock accepts, by the terms of the security, that it is a passenger.

I want to be fair to the other side.

The bull case: founder control built SpaceX. A public market cannot usually buy that kind of long-horizon vision.
The bear case: that same control removes every outside check, right when the company is making its riskiest bets.
Both are true. The mechanism is not in dispute.

The punchline sets up the next article. Dilution and control are separated by design. Every new public share adds to economics and votes one-to-one. So issuing billions in stock barely touches Musk's control. New money dilutes economics. It does not dilute Musk.

Article 5. The Index Fund You Did Not Choose

Readers ask how much BlackRock, Vanguard, Fidelity, and State Street own of SpaceX. I am going to correct the question. The correction is the better story.

Most of the passive giants own little or nothing today.

They do not buy private companies.
A private company is not in any index.
Their exposure now is minimal, except where an active fund holds a small position.

The private cap table is a different crowd. Other than Musk, the filing shows no single holder above the 5 percent line. The disclosed and reported names include:

Alphabet, Fidelity, Founders Fund, Sequoia, Andreessen Horowitz.
Valor Equity Partners, Baillie Gifford, Baron Capital, T. Rowe Price.
Blue Owl, Brookfield Growth, Capricorn, D1 Capital, Gigafund, K5 Global, Kleiner Perkins.
The Ontario Teachers' Pension Plan and Mirae Asset.
Sovereign wealth funds linked to Saudi Arabia and the UAE, with undisclosed amounts.

A few are worth singling out.

Alphabet is the standout. It put in about $900 million alongside Fidelity in 2015. Estimates put it near 7 to 7.5 percent, a stake that could be worth north of $100 billion. There is a tension here, and I will not paper over it: the prospectus reportedly says no holder exceeds 5 percent yet estimates put Alphabet near 7 percent. The likely cause is a measurement difference, plus dilution from the xAI merger. I will name the ambiguity rather than guess at a clean number. Alphabet has become the most-cited back door into SpaceX, because it is a liquid, public proxy for a private stake.
Fidelity is the other long-standing anchor. Its Contrafund alone reportedly held about $2.7 billion as of early 2025.
Baillie Gifford holds SpaceX across several London-listed trusts. That is how a lot of British retail money has gained indirect exposure.
EchoStar is a special case. It received SpaceX stock in the spectrum deal. So it sits on both the shareholder list and the use-of-proceeds list.

Now the crux. The line I most want my readers to absorb.

What turns the passive giants into large holders is index inclusion. And it runs on a known clock.

A fast track into the Nasdaq 100 is expected about fifteen trading days after the IPO.
Nasdaq rewrote its rules to allow it and dropped its minimum-float requirement.
Once SPCX enters the major indexes, every fund tracking them must buy it. Price does not matter. Governance objections do not matter.
That is when BlackRock, Vanguard, and State Street become large holders. Not by choice. By mandate. On behalf of nearly every index-fund and retirement-account-holder in the country and the world.

Read that again. You may end up owning a slice of a founder-controlled, money-losing space-and-AI conglomerate, with no governance rights. Not because you chose it. Because it landed in the index your retirement fund tracks.

A quick word on Form 13F, since I am asked.

It covers exchange-traded securities only.
It is filed quarterly on a delay of up to forty-five days, and shows only long positions.
While SpaceX was private, 13F told you nothing.
After SPCX trades, 13Fs will start to show who holds the public stock, after the first full quarter.
But 13F will never reconstruct the private cap table, the secondary vehicles, the employee holdings, or anyone's cost basis.

It is a rear-view mirror on the public float. And a slow one.

Article 6. The Trump Question, Handled Honestly

This is where I see the most heat and the least light. So I will be disciplined. Three things get conflated here. Keep them apart and you get understanding instead of outrage.

One: the Trump family's business exposure. It is indirect.

Donald Trump Jr. is a partner at 1789 Capital, a Palm Beach venture firm founded in late 2022.
The firm brands itself around patriotic capitalism and anti-ESG investing.
Its assets under management have surged over the past year, with figures cited from several hundred million up toward $3.5 billion.
1789 holds SpaceX and xAI exposure through its funds, and made well-timed bets such as Cerebras.
So the precise statement is this: the president's son is a partner in a firm that has SpaceX and xAI exposure. That is not the same as the family being a named holder on the cap table.
A separate conflict thread: companies backed by 1789 have reportedly received federal contracts and regulatory relief during the administration. That stands on its own, apart from SpaceX.

Two: the personal holdings of sitting officials. This is the unusual part.

Ethics specialists say there is no modern analog. Reported stakes total up to about $44 million across roughly ten officials.
The sharpest example is Paul McInerny, the Interior Department's chief information officer and a former SpaceX engineer. He holds between $5 million and $25 million, under an ethics waiver, even as the company has sought Fish and Wildlife Service permits near a Texas wildlife refuge.
An envoy holds between $1 million and $5 million in a vehicle whose only disclosed asset is SpaceX.
An ambassador holds between $500,000 and $1 million in xAI through a 1789 Capital fund.

Three: the counterexample. Leaving it out would be dishonest.

Kevin Warsh, who became Federal Reserve chair, was required to divest his SpaceX exposure before taking office.
So the rules are not uniformly waived. One official in a permitting-adjacent role was cleared to hold. One in the most market-sensitive job in the country was made to sell.

Should the public be concerned? Here is the even view.

The case for concern: a record listing enriches a cluster of sitting officials, some in roles that touch the company's interests, with a presidential-family-linked fund among the beneficiaries. And the disclosure rules exempt private holdings from prompt sale-reporting, so we cannot easily see when officials cash out.
The case for perspective: wealthy appointees often hold broad positions. Waivers that find remote overlap are a normal, if contestable, part of the process. Exposure through a diversified fund is weaker than a direct, role-specific stake.

My conclusion follows the facts. The family link is real but indirect. The scale of official exposure is genuinely without close precedent and deserves scrutiny. The strongest concern is structural: waivers, sensitive roles, and a disclosure gap, not proof of any specific deal. Set the McInerny permitting overlap and the Warsh divestment side by side. The tension speaks for itself.

Article 7. The Future of Space Ecosystem

This is the forward-looking close. It connects to the work I am doing on my AI and Robotics portfolio.

One caveat governs the whole article. This is landscape mapping, not a buy list. Almost every pure-play named here is pre-profit and burning cash. That is exactly the condition my Age of Austerity framework treats as a warning, not an invitation.

I split the universe into two buckets.

Bucket one: companies SpaceX is wiring itself to

The centerpiece is a chip-fabrication megaproject called Terafab.

It is a venture among SpaceX, Tesla, and xAI, with Intel as the lead foundry.
Cost estimates range from about $20 billion to figures near $119 billion.
The site is around Austin, Texas.
The goal is one terawatt of AI compute per year, with most of it aimed at orbital data centers. The pitch: sunlight is stronger in orbit, and heat sheds more easily in vacuum.

The public read-through runs to Intel and the chip-equipment names: Applied Materials, Lam Research, and Tokyo Electron. Samsung and Taiwan Semiconductor sit in the broader supply picture.

The skeptical counterweight belongs right next to it, because the company supplied it. Its own risk factors admit it cannot source enough chips for orbital AI yet, and that Terafab may fail, with partners able to walk away. For a capital-preservation reader, treat orbital compute as a high-variance option, not a base case.

Other direct ties:

EchoStar (SATS), bound in through the spectrum deal.
Cursor, a private firm under a reported acquisition option.
Tesla (TSLA), the sister company and a merger-speculation subject.
Cerebras (CBRS), not a SpaceX entity, but a fellow traveler in the AI-listing wave.

Bucket two: the broader public space economy

SpaceX's big structural effect is to collapse the cost of reaching orbit, reportedly by 99 percent or more against the historical average. That deflation grows the market for everyone who needs to put hardware in space, even as SpaceX competes with several of them. Here is the segment map I work from.

Segment	Representative public names	Note
Launch	Rocket Lab (RKLB), Firefly Aerospace (FLY)	Rocket Lab: first-quarter 2026 revenue near $200 million, up about 64 percent. Record backlog near $2.2 billion. Neutron debut pending.
Satellite operators and makers	Iridium (IRDM), Globalstar (GSAT), MDA Space (MDA), Maxar	Cash-flowing operators. Both suppliers to and rivals of Starlink.
Direct-to-device	AST SpaceMobile (ASTS), EchoStar (SATS), Viasat (VSAT)	AST is the most speculative: about $71 million of 2025 revenue against roughly $1.06 billion of capital spending. A direct rival to Starlink's direct-to-cell.
Earth observation	Planet Labs (PL), BlackSky (BKSY), Satellogic (SATL), Spire Global (SPIR)	Planet Labs is the AI-driven angle, with obligations rising on defense and intelligence wins.
Lunar and in-space services	Intuitive Machines (LUNR)	A recent award near $180 million, but negative equity and a flagged controls weakness.
Infrastructure and parts	Redwire (RDW), Karman Holdings (KRMN), Mercury Systems (MRCY)	The picks-and-shovels exposure.
Defense primes	Lockheed Martin, Northrop Grumman, L3Harris, Boeing, Honeywell	The cash-flowing ballast in most space funds.

For one-ticket exposure, the thematic funds are worth knowing, as a teaching device and nothing more.

The Procure Space fund ran up about 153 percent over the prior year, against about 30 percent for the broad market. It is heavy on the satellite operators and the speculative pure-plays.
Cathie Wood runs an active space fund leaning toward launch and adjacent robotics.

I name them to make a point, not a recommendation.

And the point ties back to my framework. The space-stock complex in 2026 shows every sign of a thematic mania:

A fund up 153 percent.
Retail sentiment swinging hard week to week.
Several flagship names burning hundreds of millions, even more than a billion, in cash against tiny revenue.
Negative equity at one prominent holding.

The SpaceX listing is the gravity well pulling the whole complex higher on sentiment. The disciplined work is to sort the names with real backlog and cash flow (the launch leader, the defense primes, the cash-flowing operators) from the pure narrative options priced for perfection (AST, Intuitive Machines, the orbital-compute thesis). That sorting is exactly what my Four-Gate Funnel is built to do. The IPO is what makes the sorting urgent rather than academic.

Article 8. How I Am Playing This Across the Portfolios

Slots in right after the ecosystem article. This is the part where the analysis stops being commentary and becomes process.

The sorting I described in the last article is not abstract. It maps directly onto three of my live portfolios. Readers ask what I am actually doing with all this, so here is my thinking, in the open.

One rule runs through everything below, so I will state it first.

The IPO itself, SPCX, fails my first gate. Gate one is financial quality and net free cash flow. A company losing about $4.94 billion a year, with negative cash flow, does not pass it.
So by my own rules, SpaceX is not a buy in any of my portfolios on listing day. Full stop. That is the discipline working, not a hot take.
What the IPO does is light up the theme. It pulls a whole complex higher on sentiment. My job is to use the Four-Gate Funnel to separate the few quality names from the many narrative ones, and to buy quality on weakness, not hype on debut.

Keep that in mind as I walk the three sleeves.

P5, AI Infrastructure and Data Center

This is where the SpaceX story lands most directly.

Terafab is, at its core, a chip fab. That is a P5 sub-bucket.
Orbital data centers are data centers. That is also a P5 sub-bucket, just moved to orbit.
The clean public read-through runs to the chip and equipment layer, names like Intel, Applied Materials, and Lam Research, and to the power and cooling layer that feeds any compute buildout, on the ground or above it.

How I act on it:

I do not buy SPCX. I run the cash-flowing infrastructure names through the Funnel, and I wait for an INSTAT floor reading before I act.
The orbital-data-center idea goes on the watchlist as a possible new sub-bucket. I tag it high-variance, because the company's own filing admits it cannot yet source the chips and that the project may fail.
The austerity lens decides the tilt. In a capital-scarce world, the infrastructure names with real backlog and real cash flow are the survivors. The narrative names are the risk. P5 owns the survivors.

The IPO does not change what I buy here. It makes the buying urgent, because it puts the whole infrastructure theme in play at once.

P6, AI and Robotics

This is the sleeve I am building from scratch, with nine sub-themes and a five-criterion rubric. The SpaceX event is a live stress test for that rubric.

SpaceX is now an AI conglomerate, so the headline fits the theme. But SPCX still fails gate one, so it does not advance.
The robotics thread is real. Terafab is explicitly meant to make chips for Optimus and for autonomous systems. Space robotics, satellite servicing, and lunar landers all sit near this sleeve.
The mania is exactly what the rubric is for. A quality name with real cash flow, like Intuitive Surgical, clears the bar. A narrative name with negative equity and a flagged controls weakness, like Intuitive Machines, does not. The IPO is what makes that ranking urgent rather than academic.

How I act on it:

A space-robotics and autonomy sub-theme may earn a slot on the P6 watchlist.
Only names that clear the quality criterion advance to the timing gates. The rest stay on the page as a study, not a position.

P7, pending one confirmation from me

Note for the editor, not the reader: the June 1 rebuild moved the AI sleeve into P5 and P6, which displaced the old Income and Tax-Exempt mandates. I have written this section both ways. I will keep only the correct one.

If P7 is the Income sleeve:

The space complex mostly screens out here. SpaceX pays no dividend and loses money. The pure-plays burn cash. None of that belongs in an income mandate.
The only income-eligible exposure to the theme is the cash-flowing dividend ballast: the defense primes such as Lockheed Martin, Northrop Grumman, and Honeywell, and a small set of established, profitable operators.
The lesson for readers is the discipline itself. A loss-making growth story has no place in an income sleeve, however exciting the rocket footage.

If P7 is the Tax-Exempt sleeve:

This sleeve holds tax-inefficient assets, the REITs, high-yield, and preferreds that you want sheltered.
The tangential link to the theme is digital-infrastructure and data-center REITs, which benefit from the same AI compute buildout that SpaceX is chasing.
SPCX itself does not fit. It throws off no income to shelter, so it has no reason to sit in a registered account.

Either way the takeaway is the same. The mandate keeps the mania out. That is the point of having mandates.

The one line I want readers to keep

The IPO does not change my process. It tests it.

SPCX fails my first gate, so I do not own it on listing day.
The theme it ignites is real, so I use the Funnel to find the few quality names inside it.
Separating the quality from the narrative is the whole job. A mania just makes the job urgent.

Article 9. What You Can Actually Do

I will not tell you to buy or to avoid this stock. I am a retired fiduciary, not your advisor. The decision is yours. What I can hand you is the discipline I would apply to a client’s capital. Six judgments.

Know what you are buying. It is an AI conglomerate with a rocket subsidiary, not a pure-play launch company. It loses money today. Price it as the former.
Recognize you have no vote. About 82 percent of control sits on a 42 percent stake. Disputes go to arbitration, not courts. Only Musk can remove Musk. You are buying economics, not a say.
Expect to own it indirectly. After Nasdaq 100 inclusion, your index funds will buy SPCX whether you analyzed it or not. If you own the broad market, you cannot fully avoid it. So decide, on purpose, how much of this exposure you want through the back door.
Do not confuse price support with value. A thin float, a big syndicate, and forced index buying can hold a price up for a while. That is mechanics, not endorsement. Morningstar's $780 billion against a $1.77 trillion mark is the size of the gap.
Sort the ecosystem by cash flow, not by story. Run every adjacent name through the same gate. Real backlog? Visible cash flow? Healthy balance sheet? Avoid the narrative options priced for perfection, however thrilling the story.
Watch the lockup. The structure is unusual: a phased release, not a single cliff. Musk himself is locked for well over a year, and most pre-IPO stock is under extended restriction. The first six months decide how much real supply hits the market. The index support that props the early price can fade as that supply arrives.

The whole series reduces to one sentence. This is a historic, maybe era-defining company, offered at a price that requires its best case to come true, with a structure that gives the buyer no recourse if it does not, and a near-term price held aloft more by index mechanics than by cash flow.

Article 10. What to Watch Before and After June 12

I publish nothing as settled that is not settled. Here is the honest list of open questions. Each one becomes a follow-up piece.

The Alphabet reconciliation. Square the roughly 7 percent estimate against the filing's "no holder above 5 percent" line. The likely answer is a measurement difference. Confirming it lets me state the true concentration cleanly.
The final float and lockup schedule. Together they decide how much stock can trade in the first six months, and how durable the index-driven price support is.
The mid-June ethics disclosures. They may show whether any officials cut their SpaceX or xAI exposure before the listing.
The Tesla-merger talk. Whether it stays rumor or shows real steps, it is the single largest future-dilution and governance risk.
Terafab milestones. Whether it moves from concept to construction, and hits early chip targets, is the swing factor for the orbital-compute thesis and the Intel read-through.
The first 13Fs. Once SPCX trades and the first filings land after its first public quarter, we will see how large the BlackRock, Vanguard, and State Street positions really are.

In summary: the ownership and dilution questions are directionally clear. But many important figures still depend on the final filing, the lockup terms, and the first quarter of public ownership. I would like to tell you the whole story, but that’s not yet possible.

Share your thoughts